Biogen BIIB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $97.5M-84.6% | $319.5M+32.8% | $0-100% | $466.5M+20.1% | $634.8M+8.8% | ||
| $236.1M+21.5% | $204.4M+11.6% | $200.2M+8.8% | $202.2M+10.6% | $194.3M+22.3% | ||
| $77.4M+3.3% | $84M+3.7% | $59.6M-20.6% | $75.3M+3.6% | $74.9M+6.1% | ||
| $448.9M+179% | $645.5M+149% | $511.9M-32.7% | $1.27B+36.0% | $160.9M-74.3% | ||
| $40.9M+53.8% | $51.2M+38.0% | $43.9M+11.7% | $46.2M+32.0% | $26.6M-20.6% | ||
| —— | —— | —— | $0-100% | —— | ||
| -$3.84B-6,635% | -$209.5M-343% | -$1.23B-6,522% | -$35.1M+97.0% | -$57M-112% | ||
| —— | —— | $433.28M— | $433.28M— | $433.28M— | ||
| —— | —— | —— | —— | $1.75B+600% | ||
| $1.3B+11,177% | -$43.8M-90.4% | -$137M— | -$130.2M-1,873% | -$11.7M+95.2% | ||
| -$2.09B-2,371% | $392.2M+108% | —— | $1.11B— | $92.2M-89.1% | ||
| $408M+204% | $594.3M+167% | $468M-35.1% | $1.23B+36.2% | $134.3M-77.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biogen generate?
- Biogen (BIIB) generated $2.9B in operating cash flow over the trailing twelve months.
- What is Biogen's free cash flow?
- After $182.2M of capital expenditures, Biogen's free cash flow was $2.7B over the trailing twelve months, up 36.3% year over year.
- Where does Biogen's cash flow data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
